Pierre Fabre Group
Market Access role at Pierre Fabre focusing on oncology for the Benelux (Belgium, Netherlands, Luxembourg) region. The position supports market access and reimbursement activities, collaborating with medical and commercial teams to prepare regional value communication and submissions. It is aimed at early-career candidates with a Master’s or PharmD and interest in national HTA and pricing systems.
Founded in 1962 by Mr. Pierre Fabre, Pierre Fabre is an international French pharmaceutical and dermo-cosmetic group owned by a public benefit foundation and its employees.
Naos appoints Frédéric Ennabli, former Pierre Fabre executive, as board chairman
Sep 29, 2025
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
Oct 10, 2022
Pierre Fabre Has Acquired Dermocosmetics Brand Même
May 9, 2023
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pierre Fabre Group.
Pierre Fabre Group didn’t post a salary, so this is our estimate from similar listings.
Eric Ducournau Named Chief Executive Officer of the Pierre Fabre Group
May 31, 2018
Market Access Director, BeLux
Revolution Medicines
Market Access Director, Netherlands
Revolution Medicines
Manager, Market Access (Temp)
Regeneron Pharmaceuticals
Associate Director, Market Access HTA, Spain
Revolution Medicines
Consultant HTA & Market Access
IQVIA
Market Access Director France, Belgium and Luxembourg
BeOne Medicines